The 30th Annual Meeting of the JapaneseSociety for Neuroendovascular Therapy
Venue: PACIFICO Yokohama (Yokohama)
Date: 2014.12.4 (Thu) – 6 (Sat)Dec. 4 (Thu)
Plenary Symposium1 [PS1] 8:45 -10:15
Embryology, Anatomy and Embolization: Anatomy is a language
Chairpersons： Shigeru Nemoto (Tokyo Medical and Dental University, Japan)
Shigeru Miyachi (Osaka Medical College, Japan)
Kenji Sugiu (Okayama University Graduate School of Medicine, Japan)
PS1-1 Cerebral vessel functional anatomy: from vascular pipes to chromosomes andgenes
Georges Rodesch (Diagnostic and Therapeutic Neuroradiologie Hopital Foch, France)【25min, Discussion 5min】
PS1-2 Functional anatomy of the cerebral venous system and Its related pathologicalprocesses
Masaki Komiyama (Osaka City General Hospital, Osaka, Japan)【15min ,Discussion 5min】
PS1-3 Functional anatomy and embolization of branches from (the 3rd segment of) theinternal maxillary artery
Hiro Kiyosue (Oita University Hospital,Japan)【15min ,Discussion 5min】

PS1-4 Embryology, anatomy and embolization of the spinal cord vessels
Yasunari Niimi (St. Luke's International Hospital, Japan)【15min ,Discussion 5min】

Symposium1 [S1] 10:20-11:50
Embryology, Indication and Strategy of AVM Embolization: How to use Onyx
and NBCA properly
Chairpersons： Masayuki Ezura (NHO Sendai Medical Center, Japan)
Yasunari Niimi (St. Luke's International Hospital, Japan)
Tohru Mizutani (Showa University School of Medicine, Japan)
S1-1

Indications, Method and Results of embolization of Brain AVMs with NBCA
Shushi Kominami (Chiba-Hokuso Hospital, Japan)【10min】

S1-2

Strategy of onxy embolization for cerebral arteriovenous malformation
Akira Ishii (Faculty of Medicine, Kyoto, Japan)【10min】
1

S1-3

S1-4
S1-5

Proper use of Onyx and NBCA in embolization of brain AVMs to achieve both
efficacy and safety
Tetsu Satow (National Cerebral and Cardiovascular Center, Japan)【10min】

Embolization of Intracranial AVM, Comparison of Onyx and NBCA
Yasushi Matsumoto (KOHNAN Hospital, Japan)【10min】

Strategies and technical tips on Cerebral AVM embolization
Naci Kocer (Istanbul University,Turky)【20min】【General discussion 30min】

Symposium2 [S2] 13:10-15:00
TVE and TAE for dAVF: Is TAE with Onyx effective?
Chairpersons： Naoya Kuwayama (University of Toyama, Japan)
Junichiro Satomi (Tokushima University Hospital, Japan)
Hiroyuki Kinouchi (University of Yamanashi,Japan)
S2-1

Results of transvenous embolization as a first-line treatment option for intracranial
dural arteriovenous fistula
Shuichi Tanoue (Oita University Hospital,Japan)

S2-2

Endo-vascular shunt point occlusion for dural arteriovenous fistula treatment
Koichi Satoh (Tokushima Red Cross Hospital,Japan)

S2-3

S2-7
S2-8

【10min】

Curative trans-arterial embolization for dural arteriovenous fistula
Shibata Teishiki (Kobe City Medical Center General Hospital, Japan)

S2-6【10min】

Endovascular treatment of intracranial dural arteriovenous fistula using ethylene
vinyl alcohol copolymer (ONYX)
Ichiro Nakahara (Stroke Center, Kokura Memorial Hospital, Japan)

S2-5【10min】

Trans-arterial embolization for dural arteriovenous fistulas -Usefulness andlimitation of liquid embolic materials
Kenji Sugiu (Okayama University Graduate School of Medicine, Japan)

S2-4【10min】【10min】

Clinical trial of Onyx embolization of intracranial dural arteriovenous fistulas.
-Interim reportNaoya Kuwayama (University of Toyama, Toyama, Japan)【10min】

Treatment strategy of intracranial dural AVF
Wataro Tsuruta (University of Tsukuba, Japan)【10min】

Endvascular treatment for dural arteriovenous fistulas
Shinya Kohyama (International Medical Center, Saitama Medical University, Japan)【10min】【General discussion 30min】

2

Symposium3 [S3] 15:05-16:00
Exposure to radiation of Neuroradiologists and Patients
Chairpersons： Shigeki Kobayashi (Chiba Emergency Medical Center, Japan)
Toshi Abe (Kurume University School of Medicine, Japan)
Akira Matsumura (University of Tsukuba,Japan)
S3-1

Medical radiation protection today and future
Takashi Moritake (University of Occupational and Environmental Health, Japan)【10min】

S3-2

Dosimetric survey of ocular lens of operator on neuroendovascular therapy
Hajime Sakamoto (Yamanashi University Hospital, Japan)【10min】

S3-3

Patient's exposure dose during neurointerventional procedure : Analysis andutilization method of exposure dose
Satoru Kawauchi (Toranomon Hospital, Japan)

S3-4【10min】

A simplified radiation-dose mapping simulator for the bi-plane FPD digitalangiography system
Morio Nagahata (Yamagata City Hospital SAISEIKAN, Japan)【10min】【General discussion 15min】

Symposium4 [S4] 13:10-14:10
Balloon Occlusion Test:
its determination method and indication of bypass surgery
Chairpersons：Toshiyuki Fujinaka (Osaka University, Japan)
Masahiko Kawanishi (Kagawa University Faculty of Medicine, Japan)
Satoshi Kuroda (University of Toyama, Japan)
S4-1

Comparison of Balloon Occlusion Test Between Neuroendovascular Therapy Sites
Masayuki Ezura (NHO Sendai Medical Center, Japan)

S4-2

S4-3
S4-4

【10min】

Angiographic circulation time and cerebral blood flow during balloon test occlusionof the internal carotid artery
Kenichi Sato (Kohnan Hospital, Japan)【8min】

Balloon Occlusion Test for Parent Artery Occlusion
Noriaki Matsubara (Nagoya University, Japan)【8min】

CT perfusion study with balloon occlusion test
Masatoshi Takagaki (Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan)【8min】

S4-5

Complication of temporary balloon test occlusion of the internal carotid artery
Tomohisa Shimizu (Okayama University, Japan)【8min】【General discussion 15min】

3Evening Seminar1 [ES1] 17:20-19:30
Pierre Lasjaunias Memorial Conference
Chairpersons： Makoto Negoro (Ichinomiya Nishi Hospital , Ichinomiya, Japan)
Shushi Kominami (Nippon Medical School, Japan)
Youo Iizuka (Ohashi Medical Center, Toho University, Japan)
ES1-1 As a student of Pierre Lasjaunias
Srivatanakul Kittipong (Tokai University, Japan)【15min, Discussion 5min】

ES1-2 Embryological consideration of dural AVF: The legacy of Pierre Lasjaunias
Michihiro Tanaka (Kameda Medical Center, Japan)【15min, Discussion 5min】
ES1-3 Brain AVM-a symptom rater than a single disease?
Michael Söderman (Karolinska University Hospital, Sweden) 【20min, Discussion 5min】
ES1-4 Segmental Arterio-venous shunts: from Cranial to Spinal levels
Sirintara Pongpech (Ramathibodi Hospital, Thailand)【20min, Discussion 5min】
ES1-5 Cerebral Veins:from anomalies to AVMs
Georges Rodesch (Hopital Foch,France)【30min, Discussion 5min】

Dec. 5(Fri)Plenary Symposium2 [PS2] 8:30-9:50
Visualization of Neuroendovascular surgery using prospective study and mass
dataChairpersons： Koji Iihara (Kyusyu University, Japan)
Akio Hyodo (Dokkyo Medical University, Japan)
Waro Taki (Koseikai Takeda Hospital, Japan)
PS2-1 Utilization of DPC data for registry of the neuroendovasculartherapy-JR-NET/J-ASPECT Study Validation study
Ataru Nishimura (University of Tsukuba, Japan)【15min】

PS2-2 Japanese registry of neuroendovascular therapy
Nobuyuki Sakai (Kobe City Medical Center General Hospital, Japan)【15min】

PS2-3 RESCUE-Japan： retrospective and prospective study
Shinichi Yoshimura (Hospital of Hyogo College of Medicine, Japan)【10min】

PS2-4 PLAtelet reactivity monitoring in Neuro-Endovascular Treatment Multicenter Trial(PLANET-M)
Hiroshi Yamagami (National Cerebral and Cardiovascular Center, Japan)【10min】

PS2-5 Neuroendovascular Surgery Database Construction, common surgery databaseproposal
Wataro Tsuruta (University of Tsukuba, Japan)【General discussion 20min】

4【10min】

Symposium5 [S5] 10:00-11:30
Role of academic society, acministration and company after pharmaceutical
approval
Chairpersons： Koji Ikeda (Tohoku University Hospital, Japan)
Kensuke Ishii (Pharmaceuticals and Medical Devices Agency, Japan)
Nobuyuki Sakai (Kobe City Medical Center General Hospital, Japan)
S5-1

Role of academic society in the optimization of approved indications ofneurointervention devices
Shigeki Kobayashi (Chiba Emergency Medical Center, Japan)

S5-2
S5-3
S5-4

【10min】

Purpose and significance of the post marketing surveillance
Tomoji Takigawa (Pharmaceuticals and Medical Devices Agency,Japan)【10min】

Prospects for the post marketing surveillance
Mami Hou (Pharmaceuticals and Medical Devices Agency,Japan)【10min】

Medical insurance application of medical devices
Hiroyuki Takao (Ministry of Health, Labour and Welfare,Japan)【10min】【Designated remark】
Minoru Saito (Stryker Japan K.K..)【10min】【Designated remark】
Hideshi Obitsu (TERUMO Corporation)【10min】【General discussion 30min】

Plenary Symposium3 [PS3] 13:30-15:20
Review of stent assisted coil embolization: Should we use stent, or not ?
Chairpersons： Ichiro Nakahara (Kokura Memorial Hospital, Japan)
Tomoaki Terada (University of Showa Fujigaoka Hospital, Japan)
Izumi Nagata (Koseikai Takeda Hospital, Japan)
PS3-1 Hemodynamic evaluation of stent-assisted coiling for aneurysms by clinical cases,experiments, and computer simulations
Kenichi Kono (Wakayama Rosai Hospital,Japan)【10min】

PS3-2 Result of stent assisted coil embolization for intracranial aneurysms, 286
consecutive experience of our center
Chiaki Sakai (Foundation of Biomedical Research and Innovation, Japan)【10min】

PS3-3 What is the true indication of stent-assisted intracranial aneurysm coilembolization?
Hidenori Oishi (Juntendo University School of Medicine, Japan)【10min】

PS3-4 Advantage and disadvantage of stent assisted coil embolization
Toshihiro Ishibashi (Jikei University School of Medicine, Japan)【10min】

PS3-5 Procedural complications related to stent-assisted coilingToshiaki Ueno (Teikyo University School of Medicine, Japan)【10min】

5

PS3-6 Usefulness and problem of Stent assisted aneurysmal emboization
Masaru Hirohata (Kurume University, Japan)【10min】

PS3-7 The optimal taylor-made antiplatelet therapy for stent-assisted coil embolization
Yukiko Enomoto (Gifu University, Japan)【10min】【General discussion 40min】

Symposium6 [S6] 15:25-16:25
The new stent and flow diverter for aneurysm treatment
Chairpersons： Hidenori Oishi (Juntendo University School of Medicine, Japan)
Yuichi Murayama (Jikei University School of Medicine, Japan)
Tetsu Satow (National Cerebral and Cardiovascular Center, Japan)
S6-1
S6-2

The Barrel Stent: Initial Clinical Experience
Satoshi Tateshima (Ronald Reagan UCLA Medical Center,USA)
Endovascular Treatment techniques on very widenecked【10min】
and complex

intracerebral Aneurysms
S6-3

Naci Kocer (Istanbul University,Turky)【20min】

Flow diverter pipeline
Vitor Mendes Pereira (University of Toronto,Canada)【20min】【General discussion 10min】

Dec. 6 (Sat)
Symposium7 [S7] 8:30-9:40
Intracranial cervical artery stenosis: the role of Wingspan stent
Chairpersons： Hiroshi Yamagami (National Cerebral and Cardiovascular Center, Japan)
Masaru Hirohata (Kurume University, Japan)
Toshio Higashi (Fukuoka University, Japan)
S7-1

Genetic Factor of Intracranial Atherosclerotic Stenosis, RNF213 gene mutation
related to moyamoya disease
Satoru Miyawaki (Tokyo University, Japan)

S7-2【10min】

Modified Mori classification to predict stent use in percutaneous cerebral balloon
angioplasty
Masashi Hamanaka (Acute Stroke Center, Kyoto First Red Cross Hospital, Japan) 【8min】

S7-3

S7-4

Early experiences of endovascular treatment with Wingspan stent for intracranialstenosis
Toshihiro Ueda (Stroke Center, St.Marianna University Toyoko Hospital, Japan)【8min】

Clinical results of Wingspan stenting with intracranial artery stenosis
Hirotoshi Imamura (Kobe City Medical Center General Hospital, Japan)【8min】

6S7-5Intervention for intracranial atherosclerotic disease
Raul G. Nogueira (Emory University School of Medicine ,Grady Memorial Hospital, U.S.A.)【20min】【General discussion 15min】

Plenary Symposium4 [PS4] 9:45-11:45
The new era of endovascular recanalization therapy for acute ischemic stroke:what can we do to improve outcome?
Chairpersons： Kazuo Minematsu (National Cerebral and Cardiovascular Center, Japan)
Shinichi Yoshimura (Hyogo Collage of Medicine, Japan)
Akira Ishii (Kyoto University, Japan)
PS4-1 Impact of Door to Puncture Time on Favorable Outcome in Acute Stroke Patients
Treated with Endovascular Therapy
Hiroshi Yamagami (National Cerebral and Cardiovascular Center, Japan)【10min】

PS4-2 Association of time with good clinical outcome in patients with acute recanalization
therapy
Hirotoshi Imamura (Kobe City Medical Center General Hospital, Japan)【10min】

PS4-3 Effect of protocol refinement in acute revascularization therapy to reducedoor-to-needle and door-to-puncture time
Shoji Matsumoto (Stroke Center, Kokura Memorial Hospital, Japan)【10min】

PS4-4 Drip and Ship System for Endovascular Therapy in Acute Ischemic Stroke
Manabu Shirakawa (Hyogo College of Medicine, Japan)【10min】
PS4-5 Mobile Endovascular-therapy Team is Alternative System to Patient Transfer for
Acute Ischemic Stroke
Tatsuo Amano (Toranomon Hospital, Japan)【10min】

PS4-6 Stroke Medical Cooperation with Information and Communication Technology, How
to use smart phone and tablet
Hiroyuki Takao (Jikei University School of Medicine, Japan)【10min】

PS4-7 Loss of Immediate Perfusion Could Predict Successful Recanalization Of AcuteStroke Treated With Stent Retriever
Masakazu Okawa (Ronald Reagan UCLA Medical Center , USA)

【10min】

PS4-8 What can we do to improved the clinical outcome?: Various effrots at UCLA Stroke
CenterSatoshi Tateshima (Ronald Reagan UCLA Medical Center , USA)
【General discussion 40min】

7【10min】

Symposium8 [S8] 13:00～14:35
Carotid artery stenting for high risk cases of hyperperfusion syndrome: Isstaged CAS safety?
Chairpersons： Shinichi Yoshimura (Hyogo Collage of Medicine, Japan)
Yasushi Ito (Brain Research Institute, Niigata University, Japan)
Kuniaki Ogasawara (Iwate University, Japan)
S8-1

Blood Sampling Oxygen Extraction Fraction and SPECT to anticipate
Hyperperfusion Syndrome following Elective CAS
Takahisa Mori (Shonan Kamakura General Hospital Stroke Center, Japan)

S8-2

S8-3
S8-4

Pathophysiology and prevention of hyperperfusion syndrome related to carotid
artery stenting
Eiichi Kobayashi (Chiba University Graduate School of Medicine, Japan)【10min】

Usefullnes of staged angioplasty
Kazutaka Uchida (Hyogo College of Medcine, Japan)【10min】

The effectiveness and limitations of the staged angioplasty
Keigo Shigeta (National Disaster Medical Center, Japan)

S8-5【10min】【10min】

Carotid artery stenting under general anesthesia for high-risk group ofhyperperfusion syndrome
Haruka Miyata (Stroke Center, Kokura Memorial Hospital, Japan)

S8-6

Protection of hyperperfusion syndrome after CAS:Importance of perioperative
management
Tomoaki Terada (Showa University Fujigaoka Hospital, Japan)

S8-7【10min】【10min】

Questionnaire survey regarding carotid artery stenting for patients at high risk for
cerebral hyperperfusion syndrome
Mikito Hayakawa (National Cerebral and Cardiovascular Center, Japan)【15min】【General discussion 20min】

Plenary Symposium5 [PS5] 14:40～16:10Neuroradiologist license system and carrer-path: how neurologists,neurosurgeon and female doctors learn neuroendovascular therapy?
Chairpersons： Nobuyuki Sakai (Kobe City Medical Center General Hospital, Japan)
Kazunori Toyoda (National Cerebaral and Cardiovascular Center, Japan)
Nobuhito Saito (The University of Tokyo Hospital, Japan)
PS5-1 Board certification system of JSNET in Japanese Medical Specialty Board
Masayuki Ezura (NHO Sendai Medical Center, Japan)【10min】
PS5-2 Japanese Society of Neuro-Endovascular Treatment Specialist Qualification
System. 13 years' Experience
Shigeru Nemoto (Tokyo Medical and Dental University, Japan)

8【10min】

PS5-3 Training program of neurologist for endovascular procedure
Keisuke Imai (Acute Stroke Center of Kyoto First Red Cross Hospital, Japan)【10min】

PS5-4 How to Learn Neuroendovascular therapy and Neurosurgery, its advantege andproblems
Toshiyuki Fujinaka (Osaka University,Japan)【7min】

PS5-5 The training system of neuroendovascular therapy in department of neurosurgery,
Nagoya University
Takashi Izumi (Nagoya University, Japan)
PS5-6 Career-path for Neuroradiologist among Radiologist and its problems
Syuichi Tanoue (Oita University,Oita, Japan)【7min】【7min】

PS5-7 Human resources development in concert with neurosurgeons, stroke neurologists
and neuroradiologists.
Ryota Ishibashi (Stroke Center, Kokura Memorial Hospital, Japan)【7min】

PS5-8 Career paths and related problem for female Neurointerventionist
Yukiko Enomoto (Gifu University, Gifu, Japan)【7min】【General discussion 25min】

9